| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 107.35B | 97.85B | 112.90B | 120.80B | 101.12B |
| Gross Profit | 29.95B | 24.81B | 28.74B | 31.09B | 25.93B |
| EBITDA | 17.17B | 14.26B | 19.37B | 20.43B | 17.54B |
| Net Income | 8.66B | 5.64B | 10.48B | 11.41B | 9.02B |
Balance Sheet | |||||
| Total Assets | 166.37B | 145.63B | 150.69B | 143.87B | 128.67B |
| Cash, Cash Equivalents and Short-Term Investments | 28.72B | 28.90B | 26.69B | 20.55B | 18.78B |
| Total Debt | 5.99B | 7.28B | 14.53B | 20.15B | 20.25B |
| Total Liabilities | 38.51B | 32.28B | 40.31B | 50.65B | 48.01B |
| Stockholders Equity | 127.86B | 113.35B | 110.36B | 93.21B | 80.65B |
Cash Flow | |||||
| Free Cash Flow | 9.36B | 13.12B | 15.72B | 5.08B | 4.96B |
| Operating Cash Flow | 10.83B | 15.79B | 21.45B | 8.26B | 8.23B |
| Investing Cash Flow | -7.66B | -3.73B | -6.47B | -4.42B | -4.83B |
| Financing Cash Flow | -4.92B | -9.69B | -10.67B | -2.67B | -622.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥2.09T | 22.45 | 12.05% | 1.50% | 9.27% | 3.49% | |
77 Outperform | ¥268.50B | 29.44 | ― | 1.53% | 9.71% | 54.79% | |
65 Neutral | ¥12.82T | 30.64 | 9.29% | 1.19% | 6.76% | 27.28% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥1.87T | 53.28 | 8.39% | 1.49% | 0.83% | -37.84% | |
62 Neutral | ¥60.96B | -18.45 | ― | 5.01% | -7.42% | -4245.20% | |
58 Neutral | ¥43.71B | 10.24 | ― | 0.91% | 11.44% | -4.29% |